BIOMAT Database Logo BIOMAT Database Logo

Therapeutic window for plasma haloperidol in acute schizophrenic psychosis. 1983

I Extein, and A L Pottash, and M S Gold

UI MeSH Term Description Entries
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012563 Schizophrenia, Paranoid A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Delusional Disorder,Paranoid Schizophrenia,Delusional Disorders,Disorder, Delusional,Disorders, Delusional,Paranoid Schizophrenias,Schizophrenias, Paranoid

Related Publications

I Extein, and A L Pottash, and M S Gold
A "therapeutic window" for haloperidol?
August 1986, Journal of clinical psychopharmacology,
I Extein, and A L Pottash, and M S Gold
Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
January 1985, Psychopharmacology bulletin,
I Extein, and A L Pottash, and M S Gold
Haloperidol: therapeutic window in schizophrenia.
October 1994, Journal of clinical psychopharmacology,
I Extein, and A L Pottash, and M S Gold
Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis.
November 1992, Pharmacopsychiatry,
I Extein, and A L Pottash, and M S Gold
Haloperidol plasma levels and clinical response: a therapeutic window relationship.
April 1992, The American journal of psychiatry,
I Extein, and A L Pottash, and M S Gold
Haloperidol plasma levels and clinical response: a therapeutic window relationship.
January 1988, Psychopharmacology bulletin,
I Extein, and A L Pottash, and M S Gold
Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients.
June 1984, Journal of clinical psychopharmacology,
I Extein, and A L Pottash, and M S Gold
Plasma level and effect of low-dose haloperidol in acute psychosis.
January 1984, Psychopharmacology bulletin,
I Extein, and A L Pottash, and M S Gold
Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
September 1998, Pharmacopsychiatry,
I Extein, and A L Pottash, and M S Gold
Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis.
January 1997, Clinical therapeutics,
Copied contents to your clipboard!